上银医药精选股票型发起式证券投资基金基金份额发售公告

Fund Overview - The fund is named "Shangyin Medical Selected Stock Fund" and is a type of stock investment fund [14] - The fund is managed by Shangyin Fund Management Co., Ltd. and the custodian is Changsha Bank Co., Ltd. [2][51][52] - The fund will be available for subscription from February 2, 2026, to March 2, 2026 [1][17] Subscription Details - The minimum subscription amount for the fund is set at 1,000,000 RMB for the initiators, while individual investors can start with as little as 1 RMB [6][27] - The fund is open to various types of investors, including individual investors, institutional investors, qualified foreign investors, and others permitted by regulations [5][14] - The fund does not impose a cap on the total amount raised during the subscription period, but the management may adjust the fundraising limits as necessary [5][18] Fund Structure - The fund operates as a contract-based, open-end fund with no fixed duration [14] - Investors can make multiple subscriptions during the fundraising period, but once accepted, subscription applications cannot be revoked [28][29] - The fund will issue two classes of shares: Class A and Class C, with different fee structures [14][22] Investment Strategy - The fund aims to achieve long-term stable appreciation of assets while strictly controlling risks [15] - The fund may invest in various asset classes, including stocks, stock index futures, and asset-backed securities, among others [9][10][11] Management and Custody - The fund management company was established on August 30, 2013, and is wholly owned by Shanghai Bank [51] - The custodian bank, Changsha Bank, has been operational since August 18, 1997, and is responsible for safeguarding the fund's assets [52] Regulatory Compliance - The fund has been registered with the China Securities Regulatory Commission (CSRC) and is subject to its regulations [1] - The fund's contract will become effective upon meeting the legal conditions and after verification by a statutory auditing firm [49]